医学
卡铂
顺铂
放化疗
放射治疗
内科学
肿瘤科
头颈部癌
紫杉醇
化疗
头颈部鳞状细胞癌
无进展生存期
作者
Marin Abousaud,Saagar Pamulapati,Saad Rashid,Fabiola Lozano,J. Marshall Shepherd,Busola Fowowe,Yichun Cao,Pauline Kim,Yu Liu,James E. Bates,Mark W. McDonald,Soumon Rudra,William Stokes,Jennifer H. Gross,Nicole C. Schmitt,Mark W. El‐Deiry,Mihir R. Patel,Anthea L. Hammond,Yong Teng,Conor E. Steuer
出处
期刊:JAMA otolaryngology-- head & neck surgery
[American Medical Association]
日期:2025-06-26
卷期号:151 (8): 769-776
标识
DOI:10.1001/jamaoto.2025.1706
摘要
The results of this study suggest that there were no differences in LRFS, PFS, DMFS, and OS in patients with SCCHN receiving radiotherapy with C/P vs cisplatin. These results support the use of C/P as an alternative regimen in patients who cannot receive cisplatin.
科研通智能强力驱动
Strongly Powered by AbleSci AI